Cancer research involves extensive data collection, including patient information, genetic sequences, and proprietary research findings. This data is valuable for several reasons:
Intellectual Property: Proprietary research can lead to new treatments and drugs, making it highly valuable. Financial Gain: Insider information can be sold to competitors or used for insider trading. Patient Data: Personally identifiable information (PII) and health records can be exploited for identity theft or insurance fraud.
